Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHARCO Study: Carbetocin versus Oxytocin for postpartum hemorrhage prophylaxis in high-risk obstetric patients
RBR-452bhzfPhase 4Not yet recruiting
- Sponsor
- Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
- Start
- Oct 2025
- Modality
- Peptides, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carbetocin, oxytocin and magnesium sulfate in postpartum hemorrhage (PPH) (2 arms), sponsored by Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
carbetocinoxytocinmagnesium sulfate
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on RBR-452bhzf.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-452bhzf.